Hechos sobre los medicamentos genéricos.

Generic drug product development : bioequivalence issues /
Published: (2008)

Generic drugs : stakeholders views on improving FDA's information on patents : report to congressional committees /
Published: (2023)

The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period /
by: Olson, Luke M., et al.
Published: (2013)

Making Objective Drug Evidence Revisions for New Labeling Act of 2020 : report (to accompany H.R. 5668) (including cost estimate of the Congressional Budget Office).
Published: (2020)

Prescription drugs : implications of drug labeling and off-label use : statement of Sarah F. Jagger, Director of Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U.S. House of Representatives /
by: Jagger, Sarah F.
Published: (1996)

Mosby's drugconsult.
Published: (2002)

Expanding the use of generic drugs.
Published: (2010)

Authorized generic drugs : short-term effects and long-term impact.
Published: (2011)

Retrosynthesis in the manufacture of generic drugs : selected case studies /
by: Santos, Pedro Paulo, et al.
Published: (2021)

Administered Prices. hearings before the United States Senate Committee on the Judiciary, Subcommittee on Antitrust and Monopoly, Eighty-Sixth Congress, second session, on May 10-13, 1960.
Published: (1960)

Increasing generic drug utilization : saving money for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.
Published: (2005)

Increasing generic drug utilization : saving money for patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005.
Published: (2005)

The marketing of generic drugs : a guide to counter-strategies for the technology intensive pharmaceutical companies /
by: James, Barrie G.
Published: (1981)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

Generics and bioequivalence /
Published: (1994)

Authorized generics : an interim report.
Published: (2009)

Trends in brand name and generic prescribed medicine utilization and expenditures, 1999 to 2003 /
by: Stagnitti, Marie N.
Published: (2006)

Generic drug entry prior to patent expiration : an FTC study /
Published: (2002)

Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office).
Published: (2019)

Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act : report (to accompany H.R 2374) (Including cost estimate of the Congressional Budget Office).
Published: (2020)

Journal of generic medicines.
Published: (2003)

FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988.
Published: (1989)

Generic drugs : saving money at the pharmacy.
Published: (1998)

Physician's drug handbook.
Published: (1999)

Generic substitution and prescription drug prices : economic effects of state drug product selection laws /
by: Masson, Alison, et al.
Published: (1985)

Consejos sobre los medicamentos y los dispositivos al cuidar de otros.
Published: (2018)

Drug pricing : research on savings from generic drug use /
by: Dicken, John E.
Published: (2012)

Guidance for industry : 180-day generic drug exclusivity under the Hatch-Waxman amendments to the Federal Food, Drug, and Cosmetic Act.
Published: (1998)

Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016.
Published: (2018)

Prescription drugs : price tends for frequently used brand and generic drugs from 2000 through 2004 : report to congressional requesters.
Published: (2005)

Guidance for industry : alternate source of the active pharmaceutical ingredient in pending ANDAs.
Published: (2000)

Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014.
Published: (2017)

Entry threats and pricing in the generic drug industry /
by: Wendling, Brett
Published: (2010)

Medicamentos prescritos.
Published: (2005)

FDA-approved bargain drugs : generic products must meet high standards.
Published: (2003)

Quick tips, when getting a prescription.
Published: (2002)